Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology
|
November 15, 2023
A Plasma Exosomal Metabolic Profiling of Nonalcoholic Fatty Liver Disease Patients Complicated with Impaired Fasting Glucose
Weiyun Jiang, Qiaofei Jin, Chunqing Li, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology
|
March 7, 2024
A Plasma Exosomal Metabolic Profiling of Nonalcoholic Fatty Liver Disease Patients Complicated with Impaired Fasting Glucose
Weiyun Jiang, Qiaofei Jin, Chunqing Li, et al.
Rheumatology International
|
January 28, 2009
Wegener's granulomatosis complicated by central diabetes insipidus and peripheral neutrophy with normal pituitary in a patient
Jing Xue, Huiying Wang, Huaxiang Wu, et al.
Frontiers in Immunology
|
June 29, 2026
Early on-treatment dynamics predicting hepatitis B e antigen seroconversion in chronic hepatitis B
Kai Yu, Huaguo Shao, Qiaofei Jin, et al.
Medicine
|
April 4, 2025
Primary sclerosing cholangitis with PLKR and UGT1A1 mutation manifested as recurrent bile duct stones: A case report
Yijun Zhou, Wei Shen, Yusheng Cui, et al.
Microbiology Spectrum
|
January 5, 2026
Variation in microbiome and metabolites is associated with advantageous effects of cholestyramine on primary biliary cholangitis with pruritus
Yijun Zhou, Gaoxiang Ying, Wei Shen, et al.
Peerj
|
November 4, 2025
Clinical value of serum HBV RNA in patients with chronic hepatitis B during antiviral therapy
Xiaojing Zhang, Fengmin Lu, Rui Wu, et al.
Med (New York, N.Y.)
|
September 21, 2024
Gut microbiome pattern impacts treatment response in primary biliary cholangitis
Qiaoyan Liu, Bingyuan Huang, Yijun Zhou, et al.
Trials
|
November 28, 2024
Comparisons of efficacy and safety of 400 or 800 ml bacterial count fecal microbiota transplantation in the treatment of recurrent hepatic encephalopathy: a multicenter prospective randomized controlled trial in China
Pengfei Zou, Yunjiao Bi, Zhaowei Tong, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology
|
November 15, 2023
A Plasma Exosomal Metabolic Profiling of Nonalcoholic Fatty Liver Disease Patients Complicated with Impaired Fasting Glucose
Weiyun Jiang, Qiaofei Jin, Chunqing Li, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology
|
March 7, 2024
A Plasma Exosomal Metabolic Profiling of Nonalcoholic Fatty Liver Disease Patients Complicated with Impaired Fasting Glucose
Weiyun Jiang, Qiaofei Jin, Chunqing Li, et al.
Rheumatology International
|
January 28, 2009
Wegener's granulomatosis complicated by central diabetes insipidus and peripheral neutrophy with normal pituitary in a patient
Jing Xue, Huiying Wang, Huaxiang Wu, et al.
Frontiers in Immunology
|
June 29, 2026
Early on-treatment dynamics predicting hepatitis B e antigen seroconversion in chronic hepatitis B
Kai Yu, Huaguo Shao, Qiaofei Jin, et al.
Medicine
|
April 4, 2025
Primary sclerosing cholangitis with PLKR and UGT1A1 mutation manifested as recurrent bile duct stones: A case report
Yijun Zhou, Wei Shen, Yusheng Cui, et al.
Microbiology Spectrum
|
January 5, 2026
Variation in microbiome and metabolites is associated with advantageous effects of cholestyramine on primary biliary cholangitis with pruritus
Yijun Zhou, Gaoxiang Ying, Wei Shen, et al.
Peerj
|
November 4, 2025
Clinical value of serum HBV RNA in patients with chronic hepatitis B during antiviral therapy
Xiaojing Zhang, Fengmin Lu, Rui Wu, et al.
Med (New York, N.Y.)
|
September 21, 2024
Gut microbiome pattern impacts treatment response in primary biliary cholangitis
Qiaoyan Liu, Bingyuan Huang, Yijun Zhou, et al.
Trials
|
November 28, 2024
Comparisons of efficacy and safety of 400 or 800 ml bacterial count fecal microbiota transplantation in the treatment of recurrent hepatic encephalopathy: a multicenter prospective randomized controlled trial in China
Pengfei Zou, Yunjiao Bi, Zhaowei Tong, et al.
Page
of 1